Novo Nordisk reported DKK26.89B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Bausch Health Companies USD 179M 31M Sep/2025
Bristol-Myers Squibb USD 2.2B 891M Sep/2025
Eli Lilly USD 5.58B 78M Sep/2025
GlaxoSmithKline GBP 2.01B 570M Sep/2025
Merck USD 2.96B 2.82B Dec/2025
Novartis USD 3.93B 96M Sep/2025
Novo Nordisk DKK 26.89B 388M Dec/2025
Novo Nordisk DKK 4.03B 25.01B Jun/2025
Pacira USD 5.43M 10.28M Sep/2025
Sanofi EUR -801M 3.6B Dec/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025